trial
as of 2026-07-01Cognitive Remediation Therapy in Schizophrenia: Effects on BDNF Levels
NCTId NCT02341131
at a glance
— · Completed
Enrollment 70 (actual)
Sponsored by Hospital Clinic of Barcelona
Primary completion 2015-12
Synthesized from structured facts only — each point cited above.
Design & status
Phase
—
Status
Completed
Enrollment
70 (actual)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Single
Start
2012-01
Primary completion
2015-12
Eligibility
ALL · 18 Years · 65 Years
Interventions & indications
Sponsors
Hospital Clinic of BarcelonaLead Sponsor
University of BarcelonaCollaborator
Investigators
1
Rafael Octavio Stryjer, M.D.Principal Investigator
Sites
1 total
Barcelona, Spain
Facts & assertions
4 sourced
Enrollment
70
Phase
NA
Primary Completion Date
2015-12
Status
COMPLETED
relationships
The graph out of here
drug
lead_sponsor
company
collaborator
company
indication
indication
indication
investigator